In accordance with the agreement, Philochem will get $350 million up front and could get up to $1 billion in milestone ...

Exclusive: R.T. Thorne’s acclaimed action-thriller doesn't open until July 2, but select audiences can see it for free on the ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb ...

Before she became a Duchess or even worked at Pearson Hardman, Meghan Markle was already a princess, but Castle put a little ...

Bristol-Myers Squibb ($BMY), a pharmaceutical giant, is trading at $49.73, far below its intrinsic value of $146.45, as calculated using the Buffett and ...

Chris Colfer is still in touch with some of the "living legends" he worked with on Glee. The 35-year-old actor shot to fame ...

Bristol Myers Squibb didn’t want to choose between clinical expertise and financial know-how when selecting a new leader. | ...

Bristol Myers Squibb has appointed Wendy Bartie as EVP, corporate affairs. Bartie started in the role this month, BMS said on ...

Bristol-Myers Squibb dropped some good news for patients and investors with its latest Phase 3 POETYK PsA-1 trial results for ...

Late-breaking data reveal durable improvements in joint, skin, and quality of life outcomes with deucravacitinib.

BMS entered the radiopharma space via its $4.1 billion buyout of RayzeBio at the end of 2023. Unlike Novartis’ approved ...